FABP4 and type 2 diabetes mellitus: FABP4 has been shown to play a significant role in the development of insulin resistance, type 2 diabetes mellitus and atherosclerosis through its action at the interface of metabolic and inflammatory pathways in adipocytes and macrophages3–5.